Hypotensive agents prevent patients with MSMDS from increasing their heart rate when needed.
#ACTA2
www.nature.com/articles/s41...
Hypotensive agents prevent patients with MSMDS from increasing their heart rate when needed.
#ACTA2
www.nature.com/articles/s41...
🔗 insight.jci.org/articles/vie...
🔗 insight.jci.org/articles/vie...
Help it travel far, and let’s wish together for a 2026 with effective treatments for children with MSMDS.
✨
#ACTA2 #MSMDS #SmoothMuscle
Help it travel far, and let’s wish together for a 2026 with effective treatments for children with MSMDS.
✨
#ACTA2 #MSMDS #SmoothMuscle
If you’d like to be part of the final push in 2025, we’d welcome it 🤗
www.acta2alliance.org/support_MSMD...
#ACTA2 #RareDisease #SmoothMuscle
If you’d like to be part of the final push in 2025, we’d welcome it 🤗
www.acta2alliance.org/support_MSMD...
#ACTA2 #RareDisease #SmoothMuscle
docs.google.com/spreadsheets...
#ACTA2 #MSMDS #RareDisease #Research
docs.google.com/spreadsheets...
#ACTA2 #MSMDS #RareDisease #Research
And to our community: you also have the chance to be part of this journey. By supporting research, you help discoveries like this one move closer to real treatments. This is how: bit.ly/MSMDS-Resear...
And to our community: you also have the chance to be part of this journey. By supporting research, you help discoveries like this one move closer to real treatments. This is how: bit.ly/MSMDS-Resear...
✨ Proud of how far this journey has come
✨ Grateful to researchers & clinicians leading the way
✨ Hopeful because we are getting closer to therapies our children need
✨ Proud of how far this journey has come
✨ Grateful to researchers & clinicians leading the way
✨ Hopeful because we are getting closer to therapies our children need
It’s a proof of concept that our rare disease can lead the way to treatments for other severe vascular diseases, like Moyamoya.
#vasculardiseases
It’s a proof of concept that our rare disease can lead the way to treatments for other severe vascular diseases, like Moyamoya.
#vasculardiseases
Today, we can celebrate that this effort is now peer-reviewed & published in @nature.com! 🎉
t.co/6WjTMRnAOi
#MSMDS #ACTA2 @markelindsay.bsky.social @bkleinstiver.bsky.social
Today, we can celebrate that this effort is now peer-reviewed & published in @nature.com! 🎉
t.co/6WjTMRnAOi
#MSMDS #ACTA2 @markelindsay.bsky.social @bkleinstiver.bsky.social
To make revascularization safer for kids with MSMDS, docs/families reach out with your experience to msmds@acta2alliance.org
#ACTA2 #StrokeAwareness #TIAs
To make revascularization safer for kids with MSMDS, docs/families reach out with your experience to msmds@acta2alliance.org
#ACTA2 #StrokeAwareness #TIAs
Built with families, experts & @SanfordResearch, it’s a powerful step to advance research & care.
Join, share, and learn more: www.acta2alliance.org/multisystemi...
#MSMDS #ACTA2 #PatientRegistry
Built with families, experts & @SanfordResearch, it’s a powerful step to advance research & care.
Join, share, and learn more: www.acta2alliance.org/multisystemi...
#MSMDS #ACTA2 #PatientRegistry
@urneuroscience.bsky.social @cvsuor.bsky.social @flaumeye.bsky.social @uofrbme.bsky.social #FluorescenceFriday
@urneuroscience.bsky.social @cvsuor.bsky.social @flaumeye.bsky.social @uofrbme.bsky.social #FluorescenceFriday
‼️Must follow for vascular health specialists around the globe.
#VascularHealth #Vascular #CommunityGrowth
vascularvoice.org
Visit our webpage and join us on our journey to connect organisations and individuals across the wider vascular community 🟢.
@acta2alliance.bsky.social @aorticdissectct.bsky.social @ehlersdanlos.bsky.social
‼️Must follow for vascular health specialists around the globe.
#VascularHealth #Vascular #CommunityGrowth
📼Watch, learn, and share: bit.ly/2025Conferen...
#ACTA2 #MSMDS #RareDisease #GeneticDisease #VascularDisease #PediatricStroke #AorticDissection #Mydriasis
📼Watch, learn, and share: bit.ly/2025Conferen...
#ACTA2 #MSMDS #RareDisease #GeneticDisease #VascularDisease #PediatricStroke #AorticDissection #Mydriasis